Influence of ligand charge and pi-expansion on DNA binding ability of protic ruthenium complexes with light-activated anticancer activity.
Kuehner Elena C EC, Khweis Sarah A SA, Petersen Courtney M CM, Patel Ish I et al.
Photoactivated Ru(II) polypyridyl complexes containing diprotic ligands and extended π systems have been synthesized and investigated as anticancer agents in cell studies. The DNA binding properties of the photoactivated ruthenium complexes [(bphen)2Ru(4,4'-dhbp)]Cl2 (1A), [(dppz)2Ru(4,4'-dhbp)]Cl2 (2A), [(bphen)2Ru(4,7-dhphen)]Cl2 (3A), and [(dppz)2Ru(4,7-dhphen)]Cl2 (4A) were investigated to further characterize these compounds and their mode of action (where bphen = bathophenanthroline, dppz = dipyrido[3,2-a:2',3'-c]phenazine, 4,4'-dhbp = 4,4'-dihydroxy-2,2'-bipyridine, and 4,7-dhphen = 4,7-dihydroxy-1,10-phenanthroline). Initial studies probed the DNA binding ability of these compounds by circular dichroism and UV-Visible spectroscopy, and these methods were suggestive of DNA binding but not quantitative. DNA binding was further investigated by fluorescence emission quenching in a competitive binding assay, with each Ru complex displacing ethidium bromide. Ru compounds were evaluated relative to the weak DNA binder [Ru(bpy)3]Cl2 (Lit-1) and the known DNA intercalator [(phen)2Ru(dppz)]Cl2 (Lit-2). Stern-Volmer quenching constants and competitive binding constants were determined for each compound. Trends in binding affinity indicate the role of pH-sensitive ligand charge in binding DNA, providing further insight into the structure-activity relationship of these compounds.